Practical Aspects of Bispecifics in NHL: Supportive Care and Minimizing Toxicities

By UChicago Medicine FEATURING Kaitlin Kelly

125 views

July 18, 2024

Comments 0

Strategies for Managing Toxicities of Oral Oncolytics in Breast Canc…

UNC Lineberger Comprehensive Cancer Center

A. Faso, B. Patel, K. Chen

1.5K views

2 months ago

Current Recommendations on Managing GI Adverse Reactions Associated …

Alberto Zambelli

946 views

4 months ago

Perspectives on the Effects of Time Toxicity in Breast Cancer Treatm…

Kathryn Post

J. Hutchinson

608 views

1 month ago

Oncologists' Perspectives on the Effects of Time Toxicity in Cancer …

Safiya Karim

306 views

1 month ago

Treatment Strategies for Hematocrit Control in PV

Insights from 2023 ASH Annual Meeting

A. Zhou

901 views

10 months ago

Managing Dermatologic Toxicities: Cutaneous irAEs Associated with Im…

Cleveland Clinic Taussig Cancer Institute

R. Unwala

273 views

1 month ago

Infectious Complications of Checkpoint Inhibitors: Discussing Overla…

Cleveland Clinic Taussig Cancer Institute

Z. Yetmar

209 views

1 month ago

Managing Women's Health in Menopause: Evolving Approaches for the Ma…

PleXus Communications

J. Simon, T. Iyer, A. Fiffick, M. Minkin

2.8K views

1 year ago

2024 Updates on Checkpoint Inhibitor Toxicities: A Nephrology Lens

Cleveland Clinic Taussig Cancer Institute

A. Mehdi

205 views

1 month ago

Practice-Changing Abstracts in NHL and HL From ASH 2023

UChicago Medicine

S. Smith

400 views

8 months ago

Systemic Therapies for Melanoma and Immune Related Adverse Effects (…

Melanoma Research Foundation

S. Chandra

38 views

1 month ago

Immunization Guidelines: What You Need to Know

Scripps Health

N. Crum-Cianflone

1.2K views

1 year ago

ESMO 2024 Insights: Current and Future Use of EGFR-Targeted Agents i…

2024 ESMO Annual Meeting Insights Hub

P. Garrido

138 views

1 month ago

Safety Profile of Ruxolitinib in Patients With MF

Icahn School of Medicine at Mount Sinai

D. Tremblay

857 views

1 year ago

The Role of Primary Care for Cancer Patients

Total Health

M. Stanford

324 views

4 months ago

Treatment Approaches in Bone Metastases Pain Management

Francesco Massari

1.5K views

1 year ago

How the Experts Manage: ADC-Associated Toxicities in NSCLC

MI&T Congressi

N. Leighl

171 views

3 months ago

Referral to Eye Care Provider for Management of Ocular Toxicity Asso…

Debra Richardson

102 views

2 months ago

MAJIC-PV Trial: Ruxolitinib vs. Best Available Therapy for PV Intole…

ASH 2022 Conference Coverage

M. McMullin

1.1K views

1 year ago

Prevalence and Prediction of Ruxolitinib Treatment Emergent Thromboc…

Insights from 2023 ASH Annual Meeting

D. Tremblay

432 views

11 months ago

Login

Login

Join VuMedi

Practical Aspects of Bispecifics in NHL: Supportive Care and Minimizing Toxicities

Recommended

Strategies for Managing Toxicities of Oral Oncolytics in Breast Canc…

Current Recommendations on Managing GI Adverse Reactions Associated …

Perspectives on the Effects of Time Toxicity in Breast Cancer Treatm…

Oncologists' Perspectives on the Effects of Time Toxicity in Cancer …

Treatment Strategies for Hematocrit Control in PV

Managing Dermatologic Toxicities: Cutaneous irAEs Associated with Im…

Infectious Complications of Checkpoint Inhibitors: Discussing Overla…

Managing Women's Health in Menopause: Evolving Approaches for the Ma…

2024 Updates on Checkpoint Inhibitor Toxicities: A Nephrology Lens

Practice-Changing Abstracts in NHL and HL From ASH 2023

Systemic Therapies for Melanoma and Immune Related Adverse Effects (…

Immunization Guidelines: What You Need to Know

ESMO 2024 Insights: Current and Future Use of EGFR-Targeted Agents i…

Safety Profile of Ruxolitinib in Patients With MF

The Role of Primary Care for Cancer Patients

Treatment Approaches in Bone Metastases Pain Management

How the Experts Manage: ADC-Associated Toxicities in NSCLC

Referral to Eye Care Provider for Management of Ocular Toxicity Asso…

MAJIC-PV Trial: Ruxolitinib vs. Best Available Therapy for PV Intole…

Prevalence and Prediction of Ruxolitinib Treatment Emergent Thromboc…